Allergan Launches Spotlyte: Digital Hub Will Educate Consumers About Medical Aesthetic Treatments
Allergan has launched Spotlyte, described as an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines. Spotlyte is the first venture from the new Allergan-owned digital ventures unit, Project Moonwalker, which is dedicated to creating consumer facing businesses that unlock opportunities in the medical aesthetics category.
Alexandra Wilkis Wilson, co-founder of Gilt Groupe and Glamsquad, and senior vice president of Consumer Strategy and Innovation at Allergan, leads the project. Spotlyte promised well-researched content, product reviews and insider profiles, together with the latest beauty news and trends, offering a holistic and informative lens into these worlds. Spotlyte will provide access to a team of trained specialists ready to offer real-time support and chat directly with anyone considering medical aesthetic treatments, as well as help connect readers to local licensed providers.
In keeping with its stated goal of educating consumers and providing well researched and accurate information on medical aesthetics, the site is brand agnostic.
"We have a unique position as industry leaders to identify emerging trends in real time and change the way that consumers engage with medical aesthetics," said Alexandra Wilkis Wilson. "I have spent most of my career focused on the consumer while creating powerful brands at the intersection of technology and lifestyle. The core goal of Project Moonwalker is to enable information flow and access. Spotlyte is the first step in changing how consumers can become better educated on medical aesthetics."
"As the market leader in medical aesthetics, we have the opportunity and the responsibility to properly educate consumers and mainstream the conversation around aesthetic treatments. We want to create an open dialogue by incorporating medical aesthetics into the overall aesthetics conversation," said Brent Saunders, CEO of Allergan. "We believe the medical aesthetics market will double in 5-7 years."